A. Dejgaard

2.2k total citations
46 papers, 1.6k citations indexed

About

A. Dejgaard is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, A. Dejgaard has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in A. Dejgaard's work include Diabetes Management and Research (9 papers), Diabetes Treatment and Management (9 papers) and Pain Mechanisms and Treatments (7 papers). A. Dejgaard is often cited by papers focused on Diabetes Management and Research (9 papers), Diabetes Treatment and Management (9 papers) and Pain Mechanisms and Treatments (7 papers). A. Dejgaard collaborates with scholars based in Denmark, United Kingdom and Norway. A. Dejgaard's co-authors include H.‐H. Parving, Søren H. Sindrup, Lars F. Gram, T. Aaes‐Jørgensen, Kim Brøsen, Ulla Bjerre, Jens J. Holst, Jørgen Frøkiær, Søren Rittig and Agnete Parving and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Pain.

In The Last Decade

A. Dejgaard

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Dejgaard Denmark 17 804 357 329 325 234 46 1.6k
Masanori Wakisaka Japan 24 433 0.5× 543 1.5× 290 0.9× 554 1.7× 307 1.3× 71 1.9k
Paul R. Standley United States 30 589 0.7× 619 1.7× 312 0.9× 590 1.8× 407 1.7× 65 2.3k
Ikuyo Kusaka Japan 22 560 0.7× 394 1.1× 313 1.0× 248 0.8× 223 1.0× 52 1.4k
Takahiko Kawamura Japan 20 472 0.6× 398 1.1× 153 0.5× 475 1.5× 359 1.5× 37 2.0k
Yukio Miura Japan 23 712 0.9× 440 1.2× 567 1.7× 165 0.5× 564 2.4× 101 2.0k
Anastasios Kalofoutis Greece 26 462 0.6× 459 1.3× 297 0.9× 365 1.1× 376 1.6× 58 2.3k
John Nadeau United States 18 530 0.7× 317 0.9× 473 1.4× 384 1.2× 539 2.3× 30 1.9k
Jeremy Gilbert Canada 17 511 0.6× 191 0.5× 302 0.9× 167 0.5× 122 0.5× 42 1.2k
Karen Tornøe Denmark 14 1.1k 1.4× 553 1.5× 482 1.5× 183 0.6× 118 0.5× 28 1.5k
Julius Sagel United States 19 599 0.7× 149 0.4× 231 0.7× 127 0.4× 326 1.4× 50 1.5k

Countries citing papers authored by A. Dejgaard

Since Specialization
Citations

This map shows the geographic impact of A. Dejgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dejgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dejgaard more than expected).

Fields of papers citing papers by A. Dejgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Dejgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dejgaard. The network helps show where A. Dejgaard may publish in the future.

Co-authorship network of co-authors of A. Dejgaard

This figure shows the co-authorship network connecting the top 25 collaborators of A. Dejgaard. A scholar is included among the top collaborators of A. Dejgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Dejgaard. A. Dejgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dejgaard, A., Jørgen Frøkiær, Jens J. Holst, et al.. (2013). Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin--angiotensin--aldosterone system in healthy men. Endocrine Abstracts. 1 indexed citations
2.
Dejgaard, A., Jørgen Frøkiær, Jens J. Holst, et al.. (2013). Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. 98(4). E664–E671. 180 indexed citations
3.
Dejgaard, A., Helle Lynggaard, Jacob Råstam, & Michael Thomsen. (2009). No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. Diabetologia. 52(12). 2507–2512. 89 indexed citations
4.
Rosenfalck, A., et al.. (2007). Impaired first‐phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 67(3). 327–336. 9 indexed citations
5.
Dejgaard, A.. (2003). Update on Novo Nordisk's clinical trial programme on NovoSeven®. Blood Coagulation & Fibrinolysis. 14(SUPPLEMENT 1). S39–S41. 26 indexed citations
6.
Madsbad, Sten, et al.. (2001). Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1‐year multicentre study. Diabetic Medicine. 18(5). 395–401. 49 indexed citations
7.
Dejgaard, A.. (1998). Pathophysiology and treatment of diabetic neuropathy. Diabetic Medicine. 15(2). 97–112. 39 indexed citations
8.
Dejgaard, A., Peter Andersen, A. Hvidberg, & J. Hilsted. (1996). Cardiovascular, Metabolic, and Hormonal Responses to Noradrenaline in Diabetic Patients with Autonomic Neuropathy. Diabetic Medicine. 13(11). 983–989. 7 indexed citations
9.
Sindrup, Søren H., Ulla Bjerre, A. Dejgaard, et al.. (1992). The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clinical Pharmacology & Therapeutics. 52(5). 547–552. 228 indexed citations
10.
Dejgaard, A., et al.. (1991). Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity. Scandinavian Journal of Clinical and Laboratory Investigation. 51(8). 659–666. 3 indexed citations
11.
Dejgaard, A., Anders Gade, Henrik Larsson, et al.. (1991). Evidence for Diabetic Encephalopathy. Diabetic Medicine. 8(2). 162–167. 123 indexed citations
12.
Gall, M.‐A., Peter Rossing, P. Damsbo, et al.. (1991). Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 34(9). 655–661. 285 indexed citations
13.
Knigge, Ulrich, et al.. (1990). Histamine-induced paradoxical GH response to TRH/GnRH in men and women: Dependence on gonadal steroid hormones. European Journal of Endocrinology. 122(3). 354–360. 4 indexed citations
14.
Parving, Agnete, et al.. (1990). Hearing Disorders in Patients with Insulin-Dependent Diabetes mellitus. International Journal of Audiology. 29(3). 113–121. 52 indexed citations
15.
Knigge, Ulrich, et al.. (1989). Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in men with duodenal ulcer. European Journal of Clinical Pharmacology. 37(3). 305–307. 4 indexed citations
16.
Buschard, Karsten, A. Dejgaard, Sten Madsbad, & C. Röpke. (1989). Different percentages of CD8+ lymphocytes in long-term type 1 diabetics with and without residual beta cell function.. PubMed. 12(3). 105–8. 1 indexed citations
17.
Christensen, N. J., A. Dejgaard, & J. Hilsted. (1988). Plasma dihydroxyphenylglycol (DHPG) as an index of diabetic autonomic neuropathy. Clinical Physiology. 8(6). 577–580. 7 indexed citations
18.
Andersen, Teis, A. Dejgaard, Arne Astrup, & Christian Gluud. (1987). Increased Plasma Fibronectin Concentrations in Obesity: Normalization during Weight Loss. Acta Medica Scandinavica. 222(3). 275–279. 6 indexed citations
19.
Dejgaard, A., Teis Andersen, Per Christoffersen, Inge Clemmensen, & Christian Gluud. (1984). Plasma fibronectin concentrations in morbidly obese patients. Scandinavian Journal of Clinical and Laboratory Investigation. 44(3). 207–210. 13 indexed citations
20.
Knigge, Ulrich, et al.. (1984). Modulation of Basal and LRH-Stimulated Gonadotrophin Secretion by Histamine in Normal Men. Neuroendocrinology. 38(2). 93–96. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masanori Wakisaka Breakdown of academic impact, for papers by Paul R. Standley Breakdown of academic impact, for papers by Ikuyo Kusaka Breakdown of academic impact, for papers by Takahiko Kawamura Breakdown of academic impact, for papers by Yukio Miura Breakdown of academic impact, for papers by Anastasios Kalofoutis Breakdown of academic impact, for papers by John Nadeau Breakdown of academic impact, for papers by Jeremy Gilbert Breakdown of academic impact, for papers by Karen Tornøe Breakdown of academic impact, for papers by Julius Sagel
Rankless by CCL
2026